XML 29 R18.htm IDEA: XBRL DOCUMENT v3.8.0.1
Business Segments
6 Months Ended
Dec. 31, 2017
Segment Reporting [Abstract]  
Business Segments
12.     Business Segments
The Animal Health segment manufactures and markets a broad range of products for food animals, including poultry, swine, cattle, dairy and aquaculture. The business includes net sales of medicated feed additives and other related products, nutritional specialty products and vaccines. The Mineral Nutrition segment manufactures and markets a broad range of trace minerals for food animals. The Performance Products segment manufactures and markets a variety of products for use in the personal care, automotive, industrial chemical and chemical catalyst industries.
We evaluate performance and allocate resources based on the Animal Health, Mineral Nutrition and Performance Products segments. Certain of our costs and assets are not directly attributable to these segments and we refer to these items as Corporate. We do not allocate Corporate costs or assets to the segments because they are not used to evaluate the segments’ operating results or financial position. Corporate costs include certain costs related to executive management, business technology, legal, finance, human resources and business development. Corporate assets include cash and cash equivalents, certain debt issue costs, income tax related assets and certain other assets.
We evaluate performance of our segments based on Adjusted EBITDA. We define Adjusted EBITDA as income before income taxes plus (a) interest expense, net, (b) depreciation and amortization, (c) (income) loss from, and disposal of, discontinued operations, (d) other expense or less other income, as separately reported on our consolidated statements of operations, including foreign currency gains and losses and loss on extinguishment of debt, and (e) certain items that we consider to be unusual, non-operational or non-recurring.
The accounting policies of our segments are the same as those described in the summary of significant accounting policies included herein.
Three Months
Six Months
For the Periods Ended December 31
2017
2016
2017
2016
Net sales
Animal Health
$ 132,845 $ 123,673 $ 261,686 $ 248,174
Mineral Nutrition
59,616 56,699 111,689 108,291
Performance Products
13,415 11,226 25,913 23,120
Total segments
$ 205,876 $ 191,598 $ 399,288 $ 379,585
Depreciation and amortization
Animal Health
$ 5,265 $ 5,011 $ 10,519 $ 9,909
Mineral Nutrition
584 542 1,169 1,084
Performance Products
259 235 505 453
Total segments
$ 6,108 $ 5,788 $ 12,193 $ 11,446
Adjusted EBITDA
Animal Health
$ 35,036 $ 34,609 $ 68,778 $ 67,228
Mineral Nutrition
5,614 4,741 9,330 8,729
Performance Products
264 260 512 1,002
Total segments
$ 40,914 $ 39,610 $ 78,620 $ 76,959
Three Months
Six Months
For the Periods Ended December 31
2017
2016
2017
2016
Reconciliation of income before income taxes to Adjusted EBITDA
Income before income taxes
$ 21,211 $ 19,304 $ 40,155 $ 36,876
Interest expense, net
3,050 3,872 6,168 7,779
Depreciation and amortization – Total segments
6,108 5,788 12,193 11,446
Depreciation and amortization – Corporate
523 656 1,082 1,316
Corporate costs
8,436 8,416 16,025 15,940
Acquisition-related cost of goods sold
1,422 1,671
Acquisition-related accrued compensation
487 420 924 840
Acquisition-related transaction costs
400 1,274
Pension settlement cost
1,702 1,702
Foreign currency (gains) losses, net
(323) (548) 2 (214)
Adjusted EBITDA – Total segments
$ 40,914 $ 39,610 $ 78,620 $ 76,959
As of
December 31,
2017
June 30,
2017
Identifiable assets
Animal Health
$ 465,058 $ 442,521
Mineral Nutrition
63,407 55,184
Performance Products
23,541 23,681
Total segments
552,006 521,386
Corporate
111,124 102,011
Total
$ 663,130 $ 623,397
The Animal Health segment includes all goodwill of the Company. The Animal Health segment includes advances to and investment in an equity method investee of  $3,905 and $3,719 as of December 31, 2017 and June 30, 2017, respectively. The Performance Products segment includes an investment in an equity method investee of  $624 and $516 as of December 31, 2017 and June 30, 2017, respectively. Corporate assets include cash and cash equivalents, certain debt issuance costs, income tax related assets and certain other assets.